NCT00874536

Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD)

The Effect of Omega-3 Fatty Acid Supplementation on Behavior of Children With ADHD

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: All
• Age: 6 Years – 16 Years
• Healthy volunteers: Not accepted

Summary

It is assumed that only 1/5 of children diagnosed with attention-deficit-hyperactivity disorder (ADHD) are treated. New treatment modalities are urgently needed. Omega-3 fatty acids have been used in this setting, yet results are conflicting. The parent omega-3 fatty acid alpha-linolenic acid (ALA) has only been used in one trial. 40 children diagnosed with ADHD will be randomized to consume either ALA or placebo for two months. Baseline and end assessments will include ADHD-related questionnaires and a computerized test. The investigators hypothesize that ALA supplementation will prove beneficial for children with ADHD.

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	omega-3 fatty acid alpha-linolenic acid (ALA)	3 grams of ALA-containing plant oil
DIETARY_SUPPLEMENT	Placebo

Timeline

• Start date: 2009-04-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2009-04-02
• Last updated: 2013-07-30

Locations

1 site across 1 country: Israel